TOT Biopharm International Co (HKSE:01875) Operating Cash Flow per Share : HK$0.17 (TTM As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is TOT Biopharm International Co Operating Cash Flow per Share?

TOT Biopharm International Co's operating cash flow per share for the six months ended in Dec. 2024 was HK$0.13. TOT Biopharm International Co's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2024 was HK$0.17.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of TOT Biopharm International Co was 101.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for TOT Biopharm International Co's Operating Cash Flow per Share or its related term are showing as below:

During the past 8 years, TOT Biopharm International Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was -2.00% per year. The lowest was -30.90% per year. And the median was -16.45% per year.

HKSE:01875's 3-Year OCF Growth Rate is not ranked ^*
in the Biotechnology industry.
Industry Median: 9.3
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

TOT Biopharm International Co Operating Cash Flow per Share Historical Data

The historical data trend for TOT Biopharm International Co's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TOT Biopharm International Co Operating Cash Flow per Share Chart

TOT Biopharm International Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

Get a 7-Day Free Trial

-0.55

-0.37

0.11

0.09

0.17

TOT Biopharm International Co Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Operating Cash Flow per Share	Get a 7-Day Free Trial									0.05	0.09	-0.01	0.04	0.13

Competitive Comparison of TOT Biopharm International Co's Operating Cash Flow per Share

For the Biotechnology subindustry, TOT Biopharm International Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TOT Biopharm International Co's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TOT Biopharm International Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where TOT Biopharm International Co's Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

TOT Biopharm International Co Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

TOT Biopharm International Co's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	124.28	/	725.197
	=	0.17

TOT Biopharm International Co's Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Dec. 2024 )	=	Cash Flow from Operations (Q: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2024 )
	=	94.598	/	725.197
	=	0.13

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.17

TOT Biopharm International Co Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of TOT Biopharm International Co's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

TOT Biopharm International Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TOT Biopharm International Co Ltd (HKSE:01875) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

120 Changyang Street, Suzhou Industrial Park, Suzhou, CHN, 215024

Website

https://www.totbiopharm.com.cn

TOT Biopharm International Co Ltd is a clinical-stage biopharmaceutical company dedicated to developing and commercializing oncology drugs and therapies for patients and their families, as well as medical professionals. The company has a pipeline of oncology drug candidates, which include monoclonal antibodies (mAbs) and antibody-drug conjugates (ADCs). The company generates maximum revenues from Mainland China.

Executives

Center Laboratories, Inc.	2201 Interest of corporation controlled by you
Tricor Trust (hong Kong) Limited	2301 Trustee
Chengwei Evergreen Capital, Lp	2101 Beneficial owner
Center Laboratories Inc.	2101 Beneficial owner
Chengwei Evergreen Management, Llc	2201 Interest of corporation controlled by you
Suzhou Vivo Management Consulting Partnership (limited Partnership)
Vivo (suzhou) Health Industry Investment Fund (limited Partnership)
Vivo Capital Llc
Vivo Capital Viii, Llc
Vivo Capital Fund Viii, L.p.
Prime Success International Limited	2101 Beneficial owner
Advantech Capital Ii L.p.
Advantech Capital Ii Master Investment Limited
Advantech Capital Investment V Limited
Advantech Capital Partners Ii Limited

TOT Biopharm International Co Headlines

No Headlines